Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Grossman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 23, 1998
Updating the insulin lispro fileL D Grossman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 22, 1999
The evidence for insulin lisproL D Grossman
Canadian Family Physician Medecin De Famille Canadien|February 24, 2001
Drug information needs clarificationL D Grossman
Pharmacoeconomics|January 9, 2001
The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approachG Dranitsaris, C J Longo, L D Grossman
Annals of Plastic Surgery|June 1, 1996
Angiomatoid fibrous histiocytomaL D Grossman, R R White, D A Arber
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitusL D Grossman, S L Shumak, S R George, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1990
Growth hormone suppression and nonproliferative diabetic retinopathy: a preliminary feasibility studyS L Shumak, L D Grossman, E Chew, et al.
Clinical Therapeutics|April 1, 2000
Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitusJ K Malone, J R Woodworth, V Arora, et al.
Diabetes & Metabolism|February 15, 2001
Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetesJ K Malone, H Yang, J R Woodworth, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 23, 1998
Updating the insulin lispro fileL D Grossman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 22, 1999
The evidence for insulin lisproL D Grossman
Canadian Family Physician Medecin De Famille Canadien|February 24, 2001
Drug information needs clarificationL D Grossman
Pharmacoeconomics|January 9, 2001
The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approachG Dranitsaris, C J Longo, L D Grossman
Annals of Plastic Surgery|June 1, 1996
Angiomatoid fibrous histiocytomaL D Grossman, R R White, D A Arber
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitusL D Grossman, S L Shumak, S R George, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1990
Growth hormone suppression and nonproliferative diabetic retinopathy: a preliminary feasibility studyS L Shumak, L D Grossman, E Chew, et al.
Clinical Therapeutics|April 1, 2000
Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitusJ K Malone, J R Woodworth, V Arora, et al.
Diabetes & Metabolism|February 15, 2001
Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetesJ K Malone, H Yang, J R Woodworth, et al.
Pageof 1